{"id":1373,"date":"2026-02-12T15:15:24","date_gmt":"2026-02-12T15:15:24","guid":{"rendered":"https:\/\/wickedsister.evit.com.au\/index.php\/2026\/02\/12\/actrims-2026-vidofludimus-calcium-targets-key-ms-mechanisms-data-show\/"},"modified":"2026-02-12T15:15:24","modified_gmt":"2026-02-12T15:15:24","slug":"actrims-2026-vidofludimus-calcium-targets-key-ms-mechanisms-data-show","status":"publish","type":"post","link":"https:\/\/wickedsister.evit.com.au\/index.php\/2026\/02\/12\/actrims-2026-vidofludimus-calcium-targets-key-ms-mechanisms-data-show\/","title":{"rendered":"ACTRIMS 2026: Vidofludimus calcium targets key MS mechanisms, data show"},"content":{"rendered":"<p><a href=\"https:\/\/multiplesclerosisnewstoday.com\/news-posts\/2026\/02\/12\/actrims-2026-vidofludimus-calcium-targets-key-ms-mechanisms\/\" title=\"ACTRIMS 2026: Vidofludimus calcium targets key MS mechanisms, data show\" rel=\"nofollow\"><img loading=\"lazy\" decoding=\"async\" width=\"800\" height=\"548\" src=\"https:\/\/multiplesclerosisnewstoday.com\/wp-content\/uploads\/2026\/02\/iStock-2221046857-800x548.jpg\" class=\"webfeedsFeaturedVisual wp-post-image\" alt=\"A doctor&#039;s gloved hand points to one of many images on a brain scan.\" style=\"margin: auto;margin-bottom: 15px;max-width: 100%\" data-wp-pid=\"159188\" \/><\/a><\/p>\n<p>Immunic Therapeutics&#8216; experimental oral therapy vidofludimus calcium can target key mechanisms underlying disease progression in multiple sclerosis (MS), including acute and chronic inflammation, as well as Epstein-Barr virus (EBV) reactivation, according to new trial data. The Phase 2 CALLIPER trial (NCT05054140)\u00a0investigated vidofludimus calcium against a placebo in people with progressive forms of MS. Immunic presented [&#8230;]<\/p>\n<p>The post <a href=\"https:\/\/multiplesclerosisnewstoday.com\/news-posts\/2026\/02\/12\/actrims-2026-vidofludimus-calcium-targets-key-ms-mechanisms\/\">ACTRIMS 2026: Vidofludimus calcium targets key MS mechanisms, data show<\/a> appeared first on <a href=\"https:\/\/multiplesclerosisnewstoday.com\">Multiple Sclerosis News Today<\/a>.<\/p>\n<p><em>Source: <a href=\"https:\/\/multiplesclerosisnewstoday.com\/news-posts\/2026\/02\/12\/actrims-2026-vidofludimus-calcium-targets-key-ms-mechanisms\/\" rel=\"nofollow noopener\" target=\"_blank\">multiplesclerosisnewstoday.com<\/a><\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Immunic Therapeutics&#8216; experimental oral therapy vidofludimus calcium can target key mechanisms underlying disease progression in multiple sclerosis (MS), including acute and chronic inflammation, as well as Epstein-Barr virus (EBV) reactivation, according to new trial data. The Phase 2 CALLIPER trial (NCT05054140)\u00a0investigated vidofludimus calcium against a placebo in people with progressive forms of MS. Immunic presented&#8230;<\/p>\n","protected":false},"author":0,"featured_media":1374,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[11,15,9,8,13,14,12,10],"class_list":["post-1373","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-multiple-sclerosis-research","tag-brain-repair","tag-marburg-type-ms","tag-ms","tag-multiple-sclerosis","tag-myelin","tag-neuroregeneration","tag-oligodendrocyte","tag-remyelination"],"_links":{"self":[{"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/posts\/1373","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/comments?post=1373"}],"version-history":[{"count":0,"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/posts\/1373\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/media\/1374"}],"wp:attachment":[{"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/media?parent=1373"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/categories?post=1373"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/tags?post=1373"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}